OpenAlex
PricingAboutJobs
Log inGet started
Work

A Phase 1/2 Study of the Angiogenesis Inhibitor Sorafenib in Cervical Cancer Patients Treated With Radiation Therapy

HTML

Year: 2014
Type: article
Study design: Clinical Trial
Source: International Journal of Radiation Oncology*Biology*Physics
DOI: 10.1016/j.ijrobp.2014.05.717
Authors: N. Chaudary, T.W. Fyles, C. Townsley, K. Han, R.P. Hill, S. Kim, W. Levin, H. MacKay, L. Manchul, I. Yeung, A. Oza, M. Milosevic
Institutions: Princess Margaret Cancer Centre, Women's College Hospital, Southlake Regional Health Center
Language: English

Topic: Endometrial and Cervical Cancer Treatments
Subfield: Obstetrics and Gynecology
Field: Medicine
Domain: Health Sciences
Keywords: sorafenib, cervical cancer, angiogenesis inhibition, radiotherapy, radioresistance (biology), cisplatin-based chemotherapy, multikinase inhibitor, radiosensitization, drug toxicity
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2013447111
FWCI:
Cites:
Cited by:
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security